Advanced Services for Central Pharmacy
Dispensing Designed to Support Dispensing Accuracy and Patient
Safety while Improving Clinical and Financial Outcomes
Omnicell, Inc. (Nasdaq: OMCL), a leader in transforming the
pharmacy care delivery model, today announced that Kentucky-based
Baptist Health has selected Omnicell’s Central Pharmacy Dispensing
Service in an effort to address labor challenges and improve
clinical and financial outcomes.
Labor shortages, disconnected care settings, and manual
processes continue to impact patient care for many healthcare
providers and prevent clinicians from operating at the top of their
license.
Baptist Health is one of the latest health systems to adopt
Omnicell’s Central Pharmacy Dispensing Service, which is expected
to help enhance safety and dispensing accuracy while streamlining
workflows through a combination of advanced robotics, dispensing
optimization tools, and remote and onsite experts. This
comprehensive solution is designed to automate and optimize
pharmacy labor and workflows, leading to pharmacists spending on
average 75 percent less time on dispensing tasks.1
“We selected Omnicell’s robotics and services for our Central
Pharmacy Services Center in an effort to help alleviate staffing
challenges while focusing on improving quality, patient safety, and
efficiency,” said Nilesh Desai, Chief Pharmacy Officer at Baptist
Health. “We’re excited about the opportunity to advance further
toward our vision of a fully integrated and highly automated
pharmacy solution.”
We believe automating central pharmacy tasks is critical to
achieving the Autonomous Pharmacy, an industry-defined vision to
replace manual, error-prone activities with automated processes
that are intended to be safer and more efficient.
“Baptist Health has been a leader in embracing the industry
vision of a fully autonomous pharmacy,” said Alex Pratt, senior
vice president and chief growth officer for Omnicell. “The addition
of these Advanced Services should help them move closer to that
vision while also helping to enable them to achieve their goals of
optimized clinical and financial outcomes.”
Learn more about Omnicell’s Advanced Services and the
transformation of pharmacy care at omnicell.com.
About Baptist Health
Founded in 1924 in Louisville, Kentucky, Baptist Health is a
full-spectrum health system dedicated to improving the health of
the communities it serves. The Baptist Health family consists of
nine hospitals, employed and independent physicians, and more than
400 points of care, including outpatient facilities, physician
practices and services, urgent care clinics, outpatient diagnostic
and surgery centers, home care, fitness centers, and occupational
medicine and physical therapy clinics.
Baptist Health’s eight owned hospitals include more than 2,300
licensed beds in Corbin, Elizabethtown, La Grange, Lexington,
Louisville, Paducah, Richmond and New Albany, Indiana. Baptist
Health also operates the 410-bed Baptist Health Deaconess
Madisonville in Madisonville, Kentucky in a joint venture with
Deaconess Health System based in Evansville, Indiana. Baptist
Health employs more than 22,500 people in Kentucky and surrounding
states.
Baptist Health is the first health system in the U.S. to have
all of its hospitals recognized by the American Nursing
Credentialing Center with either a Magnet® or Pathway to
Excellence® designation for nursing excellence.
Baptist Health’s employed provider network, Baptist Health
Medical Group, has more than 1,650 providers offering care in 74
specialties, including more than 780 physicians and more than 870
advanced practice clinicians. Baptist Health’s physician network
also includes more than 2,000 independent physicians.
Learn more at BaptistHealth.com.
About Omnicell
Since 1992, Omnicell has been committed to transforming the
pharmacy care delivery model in an effort to optimize financial and
clinical outcomes across all settings of care. Through a
comprehensive portfolio of automation and advanced services,
Omnicell is uniquely positioned to address evolving healthcare
challenges, connect settings of care, and streamline the medication
management process. Healthcare facilities worldwide partner with
Omnicell to help increase operational efficiency, reduce medication
errors, improve patient safety, and enhance patient engagement and
adherence, helping to reduce costly hospital readmissions. To learn
more, visit omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of
Omnicell, Inc. or one of its subsidiaries.
1 https://www.omnicell.com/customer-stories/sentara-rmh
Forward-Looking Statements
To the extent any statements contained in this press release
deal with information that is not historical, these statements are
“forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. Without limiting the
foregoing, statements including the words “expect,” “intend,”
“may,” “will,” “should,” “would,” “could,” “plan,” “potential,”
“anticipate,” “believe,” “estimate,” “seek,” “predict,” “project,”
and variations of these terms and similar expressions are intended
to identify forward-looking statements. Forward-looking statements
are subject to the occurrence of many events outside Omnicell’s
control. Such statements include, but are not limited to the
objectives and expected benefits of Omnicell’s products and
services, including expectations regarding Omnicell’s Central
Pharmacy Dispensing Service (and any implied financial impact with
the foregoing). Actual results and other events may differ
significantly from those contemplated by forward-looking statements
due to numerous factors that involve substantial known and unknown
risks and uncertainties. These risks and uncertainties include,
among other things, (i) Omnicell’s ability to take advantage of
growth opportunities and develop and commercialize new solutions
and enhance existing solutions, (ii) continued and increased
competition from current and future competitors in the medication
management automation solutions market and the medication adherence
solutions market, (iii) unfavorable general economic and market
conditions, including the impact and duration of inflationary
pressures, (iv) reduction in demand in the capital equipment market
or reduction in the demand for or adoption of our solutions,
systems, or services, (v) delays in installations of our medication
management solutions or our more complex medication packaging
systems, (vi) risks related to Omnicell’s investments in new
business strategies or initiatives, including its transition to
selling more products and services on a subscription basis, (vii)
risks related to failing to maintain expected service levels when
providing our Advanced Services or retaining our Advanced Services
customers, (viii) Omnicell’s ability to meet the demands of, or
maintain relationships with, its institutional, retail, and
specialty pharmacy customers, (ix) Omnicell’s ability to recruit
and retain skilled and motivated personnel, and (x) other risks and
uncertainties further described in the “Risk Factors” section of
Omnicell’s most recent Annual Report on Form 10-K, as well as in
Omnicell’s other reports filed with or furnished to the United
States Securities and Exchange Commission (“SEC”), available at
www.sec.gov. Forward-looking statements should be considered in
light of these risks and uncertainties. Investors and others are
cautioned not to place undue reliance on forward-looking
statements. All forward-looking statements contained in this press
release speak only as of the date of this press release. Omnicell
assumes no obligation to update any such statements publicly, or to
update the reasons actual results could differ materially from
those expressed or implied in any forward-looking statements,
whether as a result of changed circumstances, new information,
future events, or otherwise, except as required by law.
OMCL-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231102892931/en/
Betsy Martinelli Director, Corporate Marketing
betsy.martinelli@omnicell.com (412) 334-3256
Omnicell (NASDAQ:OMCL)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Omnicell (NASDAQ:OMCL)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024